The most common side effects of GLP-1 medications include nausea and vomiting, diarrhea, constipation, abdominal pain, bloating, dizziness, and fatigue
In summary, peptide molecules like semaglutide and tirzepatide have provided promising results for reducing HbA1c and reducing body weight in human phase 1 and phase 2 clinical trials
This option may be recommended for individuals who have difficulty taking vitamin B12 orally
Fagrons inspection reports also were the subject of a September 15 request in which Joanna DiStefano of SCA Pharmaceuticals requested all documents, communications and/or records related in any way to [the] FDAs 2025 inspection of Fagron Compounding Services, LLC d/b/a Fagron Sterile Services. Harvinder Bharaj of Xseer Pharmaceuticals submitted a request on September 11 that stated: a Pre-Operational Inspection on June 9th 2025 and a Pre-Operational Memo was released by the Office of Compounding Quality and Compliance Officer Zachery L Miller
Very few Glp1r + Chat + neurons were found in other cholinergic cell populations